Literature DB >> 12734047

Pathophysiology and management of pediatric ascites.

Mahmoud Sabri1, Miguel Saps, John M Peters.   

Abstract

Ascites accumulation is the product of a complex process involving hepatic, renal, systemic, hemodynamic, and neurohormonal factors. The main pathophysiologic theories of ascites formation include the "underfill," "overflow," and peripheral arterial vasodilation hypotheses. These theories are not necessarily mutually exclusive and are linked at some level by a common pathophysiologic thread: The body senses a decreased effective arterial blood volume, leading to stimulation of the sympathetic nervous system, arginine-vasopressin feedback loops, and the renin-angiotensin-aldosterone system. Cornerstones of ascites management include dietary sodium restriction and diuretics. Spironolactone is generally tried initially, with furosemide added if clinical response is suboptimal. More refractory patients require large-volume paracentesis (LVP) accompanied by volume expansion with albumin. Placement of a transjugular intrahepatic portosystemic shunt is reserved for individuals with compensated liver function who require very frequent sessions of LVP. Peritoneovenous shunts are not used in contemporary ascites management. Liver transplantation remains the definitive therapy for refractory ascites. Although treatment of ascites fails to improve survival, it benefits quality of life and limits the development of such complications as spontaneous bacterial peritonitis.

Entities:  

Mesh:

Year:  2003        PMID: 12734047     DOI: 10.1007/s11894-003-0026-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  55 in total

1.  Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis.

Authors:  M Levy; M J Wexler
Journal:  Am J Physiol       Date:  1987-10

2.  Characteristics of ascitic fluid in the alcoholic cirrhotic.

Authors:  J A Wilson; E A Suguitan; W A Cassidy; R H Parker; C H Chan
Journal:  Dig Dis Sci       Date:  1979-08       Impact factor: 3.199

3.  Large-volume paracentesis in the management of ascites in children.

Authors:  R E Kramer; R J Sokol; B Yerushalmi; E Liu; T MacKenzie; E J Hoffenberg; M R Narkewicz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-09       Impact factor: 2.839

4.  Management of Gastrointestinal Bleeding in Children.

Authors:  John M. Peters
Journal:  Curr Treat Options Gastroenterol       Date:  2002-10

Review 5.  Managing liver failure.

Authors:  D A Kelly
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

6.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.

Authors:  P Ginés; V Arroyo; E Quintero; R Planas; F Bory; J Cabrera; A Rimola; J Viver; J Camps; W Jiménez
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

7.  Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics.

Authors:  M Bernardi; L Fornalè; C Di Marco; F Trevisani; M Baraldini; A Gasbarrini; C De Collibus; F Zacà; A Ligabue; A Colantoni
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083

8.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  J Cabrera; M Maynar; R Granados; E Gorriz; R Reyes; J M Pulido-Duque; J L Rodriguez SanRoman; C Guerra; D Kravetz
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

9.  Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors.

Authors:  O Riggio; M Merlli; G Pedretti; R Servi; P Meddi; R Lionetti; P Rossi; M Bezzi; F Salvatori; U Ugolotti; F Fiaccadori; L Capocaccia
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

10.  Paracentesis of ascitic fluid. A safe procedure.

Authors:  B A Runyon
Journal:  Arch Intern Med       Date:  1986-11
View more
  1 in total

1.  Clinical value of urinary retinol-binding protein in ascites due to cirrhosis.

Authors:  Yujing Xia; Jingjing Li; Sainan Li; Tong Liu; Yuqing Zhou; Qin Yin; Jianrong Wang; Wenxia Lu; Rong Zhang; Yuanyuan Zheng; Fan Wang; Jie Lu; Kan Chen; Weiqi Dai; Yingqun Zhou; Chuanyong Guo
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.